Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.50 |
| ▸ | PRKDC | P78527 | 6/20 | 0.41 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.37 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.33 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CCNC | P24863 | 1/20 | 0.31 |
| ▸ | CDK8 | P49336 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15937278 | 0.97 | ALOX5 (0.47) | ALOX5PRKDCPARP14PIK3CDPIK3CB | |
| SCHEMBL15937299 | 0.96 | ALOX5 (0.46) | ALOX5PRKDCPARP14PIK3CDPIK3CB | |
| SCHEMBL15937300 | 0.96 | ALOX5 (0.46) | ALOX5PRKDCPARP14PIK3CDPIK3CB | |
| SCHEMBL13371826 | 0.93 | ALOX5 (0.48) | ALOX5PRKDCPARP14PIK3CDPIK3CB | |
| SCHEMBL15937270 | 0.89 | ALOX5 (0.41) | ALOX5PRKDCPARP14PIK3CDPIK3CB | |
| SCHEMBL13371849 | 0.85 | ALOX5 (0.48) | ALOX5PRKDCPARP14PIK3CDPIK3CB | |
| SCHEMBL13557722 | 0.85 | ALOX5 (0.47) | ALOX5PRKDCPARP14PIK3CDPIK3CB | |
| SCHEMBL15773207 | 0.85 | ALOX5 (0.38) | ALOX5PRKDC | |
| SCHEMBL15773166 | 0.84 | ALOX5 (0.39) | ALOX5PRKDCPARP14 | |
| SCHEMBL15497914 | 0.84 | ALOX5 (0.46) | ALOX5PRKDCPARP14PIK3CDPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160126476-A1 | NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE | LMS CO., LTD. (KR) | 2016-05-05 | — | — | US | disclosed |
| US-20160126476-A1 | NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE | LMS CO., LTD. (KR) | 2016-05-05 | — | — | US | disclosed |
| WO-2014119895-A1 | NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE | 주식회사 엘엠에스 (KR) | 2014-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160126476-A1 | NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE | ELAVL1, SUN2, PER2 | ALOX5 640/4885PRKDC 4097/4885PARP14 3721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.